Jezeršek Novaković B. Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma. Radiol Oncol [Internet]. 2016 Jan. 11 [cited 2026 Jun. 15];49(4). Available from: https://www.radioloncol.com/index.php/ro/article/view/2433